Cardiovascular Diseases Clinical Trial
To determine prospectively the role of elevated plasma triglyceride (TG) as a risk factor for 20-year coronary heart disease (CHD) mortality in familial combined hyperlipidemia (FCHL) and familial hypertriglyceridemia (FHTG), the familial forms of hypertriglyceridemia. Also, to perform genetic epidemiologic studies of recently identified lipoprotein risk factors for CHD, including Atherogenic Lipoprotein Phenotypes (ALP) based on subclasses of low-density lipoproteins (LDL), Lipoprotein(a) (Lp(a)) and apolipoprotein (apo) B plasma levels, and apo E isoforms.
BACKGROUND:
The study provided valuable new data on the role of triglyceride as a risk factor for
coronary heart disease and on the genetic epidemiology of lipoprotein risk factors, using
the only existing sample of families with hypertriglyceridemia that could be studied
prospectively.
DESIGN NARRATIVE:
Using a sample of 101 families identified and studied in Seattle in the early 1970s, the
study sought to determine if 20-year CHD mortality and all-cause mortality were increased in
siblings and offspring of probands from families with familial combined hyperlipidemia and
familial hypertriglyceridemia, compared to a group of married-in spouse controls. The study
also sought to determine if elevated plasma triglycerides at baseline predicted 20-year CHD
mortality in these family members. Based on new blood samples from these same families, the
inheritance of LAP phenotypes was investigated, the association of elevated plasma Lp(a) and
apo B levels with parental CHD mortality was examined, and the association of lipid levels
with apo E isoforms was investigated. A repository of frozen white blood cells and plasma
aliquots for future genetic studies was established.. These hypotheses were addressed by
determining the vital status of 1009 family members in the 101 families, carefully
classifying the cause of death as CHD or not for deceased family members, and by obtaining
new blood samples from three generations of these families, including both local and
non-local relatives. New personal and family history medical questionnaires were also
completed for each participant.
The study was renewed in FY 1997 through June 30, 2001. The study has three new specific
aims: to elucidate the genetic basis of small, dense, low-density lipoprotein, to map the
chromosomal location(s) of gene(s) influencing this phenotype using a whole genome screen;
to reveal common genetic influences (pleiotropic effects) on combinations of interrelated
lipoprotein risk factors; and to evaluate familial CVD risk by determining the association
between CVD in the proband generation and lipoprotein phenotypes, including lipoprotein(a)
in the younger offspring generation in specific forms of familial hyperlipidemia.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|